Inavolisib plus palbociclib-fulvestrant yields significantly longer progression-free survival than placebo plus palbociclib-fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, ...

Adjuvant durvalumab did not improve disease-free survival in patients with early-stage non-small cell lung cancer in the phase 3 BR.31 trial.

The trial (NCT04214288) included 240 patients with advanced, ER-positive, HER2-negative breast cancer ... were similar. Overall survival data were not mature at the data cutoff. The median overall ...

Two cycles of dual neoadjuvant immunotherapy (nivolumab/ipilimumab or nivolumab/relatlimab) induced high pathological ...

Spend more time watching Disney Plus and less time searching for what to watch. Use this list to find the best Movies for your Kids. And check back often! We'll be updating it daily with new arrivals.

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, ...